Display options
Cite
Sola-Valls N, Blanco Y, Sepúlveda M, et al. Telemedicine for Monitoring MS Activity and Progression. Curr Treat Options Neurol. 2015;17(11):47doi: 10.1007/s11940-015-0377-y.
Sola-Valls, N., Blanco, Y., Sepúlveda, M., Martinez-Hernandez, E., & Saiz, A. (2015). Telemedicine for Monitoring MS Activity and Progression. Current treatment options in neurology, 17(11), 47. https://doi.org/10.1007/s11940-015-0377-y
Sola-Valls, Nuria, et al. "Telemedicine for Monitoring MS Activity and Progression." Current treatment options in neurology vol. 17,11 (2015): 47. doi: https://doi.org/10.1007/s11940-015-0377-y
Sola-Valls N, Blanco Y, Sepúlveda M, Martinez-Hernandez E, Saiz A. Telemedicine for Monitoring MS Activity and Progression. Curr Treat Options Neurol. 2015 Nov;17(11):47. doi: 10.1007/s11940-015-0377-y. PMID: 26423914.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Neurol. 2015 Nov;17(11):47. doi: 10.1007/s11940-015-0377-y.

Telemedicine for Monitoring MS Activity and Progression.

Current treatment options in neurology

Nuria Sola-Valls, Yolanda Blanco, Maria Sepúlveda, Eugenia Martinez-Hernandez, Albert Saiz

Affiliations

  1. Center of Neuroimmunology and Department of Neurology, Hospital Clinic of Barcelona, Barcelona, Spain.
  2. Center of Neuroimmunology and Department of Neurology, Hospital Clinic of Barcelona, Barcelona, Spain. [email protected].
  3. Service of Neurology, Hospital Clinic and Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Center of Neuroimmunology, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain. [email protected].
  4. Service of Neurology, Hospital Clinic and Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Center of Neuroimmunology, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain.

PMID: 26423914 DOI: 10.1007/s11940-015-0377-y

Abstract

OPINION STATEMENT: Telemedicine (TM) is defined as the exchange of medical information between two different physical places. The aims of TM are to provide services that cannot easily be provided face-to-face and improve the efficiency of existing ones. Multiple sclerosis (MS) is a chronic demyelinating disease characterized by a heterogeneous array of symptoms that can lead to severe impairment and may impact on accessibility to medical services, patient's ability to function, and overall health-related quality of life (HRQoL). The use of TM to clinically monitor MS patients has demonstrated benefits by improving HRQoL and reducing associated medical costs. Patient-reported outcome (PRO) measures have been used in TM interventions, registries, and cost-efficiency studies because they offer valuable information about patient's perspective of MS disease burden. Moreover, TM has shown acceptable reliability in the assessment of the neurological impairment by Kurtzke expanded disability status scale (EDSS) and has the potential to develop more sensitive measures, such as average daily walking activity, to closely monitor MS disease progression in real environment. It is likely that the use of TM will continue to increase in the following years but larger and controlled studies are necessary to confirm the beneficial effects of TM to deliver an optimal care for patients with MS.

Keywords: Adherence; Clinical assessment; Daily walking activity; Disease activity; Disease progression; Electronic devices; Multiple sclerosis; Physical intervention; Registries and databases; Remote; Remote monitoring; Telemedicine; Teleneurology

References

  1. Int J Med Inform. 2010 Nov;79(11):736-71 - PubMed
  2. Telemed J E Health. 2011 Jan-Feb;17(1):5-13 - PubMed
  3. Neurology. 2013 Feb 12;80(7):670-6 - PubMed
  4. Mult Scler. 1998 Oct;4(5):444-51 - PubMed
  5. Biomed Eng Online. 2014 Feb 06;13:10 - PubMed
  6. BMJ. 1997 Dec 20-27;315(7123):1652-4 - PubMed
  7. Mult Scler. 2007 Nov;13(9):1176-82 - PubMed
  8. JAMA Neurol. 2015 Mar;72(3):349-54 - PubMed
  9. Mult Scler. 2012 Mar;18(3):364-71 - PubMed
  10. Health Qual Life Outcomes. 2012 Jun 18;10:70 - PubMed
  11. Arch Neurol. 1988 Jul;45(7):746-8 - PubMed
  12. Neuroepidemiology. 2013;40(2):85-92 - PubMed
  13. Mult Scler. 2012 Apr;18(4):472-80 - PubMed
  14. Mult Scler. 2014 Oct;20(11):1523-32 - PubMed
  15. J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1031-5 - PubMed
  16. Arch Phys Med Rehabil. 2013 Oct;94(10):1971-81 - PubMed
  17. Health Qual Life Outcomes. 2010 Jun 07;8:55 - PubMed
  18. Int J MS Care. 2011 Fall;13(3):137-45 - PubMed
  19. Mult Scler. 2001 Dec;7(6):405-10 - PubMed
  20. Neurology. 1999 Jan 1;52(1):63-70 - PubMed
  21. J Rehabil Med. 2011 Mar;43(4):305-10 - PubMed
  22. Mult Scler. 2006 Dec;12(6):782-6 - PubMed
  23. PLoS One. 2013 Sep 04;8(9):e73247 - PubMed
  24. BMC Neurol. 2013 Sep 10;13:119 - PubMed
  25. Ther Adv Neurol Disord. 2010 Jul;3(4):229-39 - PubMed
  26. J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):439-42 - PubMed
  27. Mult Scler. 2003 Mar;9(2):154-9 - PubMed
  28. Int J MS Care. 2013 Spring;15(1):8-14 - PubMed
  29. Arch Phys Med Rehabil. 2008 Oct;89(10):1849-56 - PubMed
  30. Patient. 2012;5(1):57-69 - PubMed
  31. Neurology. 2015 Jul 21;85(3):240-7 - PubMed
  32. J Rehabil Med. 2013 Jan;45(1):68-75 - PubMed
  33. Mult Scler. 2001 Oct;7(5):335-9 - PubMed
  34. BMC Neurol. 2014 Mar 25;14:58 - PubMed
  35. Lancet Neurol. 2005 Sep;4(9):556-66 - PubMed
  36. J Digit Imaging. 2010 Oct;23(5):632-8 - PubMed
  37. J Neurol. 2008 Dec;255 Suppl 6:102-8 - PubMed
  38. Acta Neurol Scand. 2013 Jun;127(6):384-90 - PubMed
  39. Int J Epidemiol. 1994 Feb;23(1):148-54 - PubMed
  40. Mult Scler. 2007 Jul;13(6):770-5 - PubMed
  41. BMJ. 1997 May 31;314(7094):1580-3 - PubMed
  42. Mult Scler. 2010 Apr;16(4):472-9 - PubMed
  43. Arch Phys Med Rehabil. 2010 Feb;91(2):252-60 - PubMed
  44. Lancet Neurol. 2012 May;11(5):467-76 - PubMed
  45. J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):250-5 - PubMed
  46. Lancet Neurol. 2010 Aug;9(8):820-8 - PubMed
  47. Health Qual Life Outcomes. 2013 Oct 03;11:162 - PubMed
  48. Neurology. 2015 Jun 2;84(22):e191-3 - PubMed
  49. Telemed J E Health. 2014 May;20(5):473-7 - PubMed
  50. Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):1007-22 - PubMed
  51. BMC Neurol. 2013 Apr 25;13:37 - PubMed
  52. Neurology. 2001 Apr 10;56(7):934-7 - PubMed
  53. J Telemed Telecare. 2008;14(4):190-4 - PubMed
  54. Mult Scler. 1999 Aug;5(4):223-33 - PubMed
  55. Mult Scler Int. 2010;2010:640749 - PubMed
  56. Mult Scler. 2013 Nov;19(13):1784-91 - PubMed
  57. Neurohospitalist. 2013 Jul;3(3):120-4 - PubMed

Publication Types